
zzso T cells can kill cancer zzso Cancer vaccines function by increasing the number of immune T zzso There are zzso strict zzso limits imposed on the immune system to prevent excessive zzso zzso and zzso The same biological restrictions limit cancer zzso zzso agents that circumvent the biological restrictions have been invented and formulated, including zzso zzso cell zzso and growth factors, zzso vaccine zzso zzso zzso zzso and growth factors, zzso immune checkpoint zzso and zzso agents to neutralize or inhibit zzso cells, zzso and zzso Few of these agents are broadly available for the development of effective multiple component zzso The major problem facing zzso today is a lack of broad availability of agents already in zzso The National Cancer Institute has developed a zzso ranked list of agents with high potential to serve as zzso zzso This review focuses on 12 of the agents, all with proven ability to augment zzso zzso zzso each has little chance of making substantial inroads into cancer zzso In combinations dictated by biology, the agents are overwhelmingly likely to have an zzso Future availability of these agents for development of innovative combination cancer therapy regimens will provide a benchmark for the resolve of the national cancer therapy zzso research zzso 

